Scientists Develop Antibody for Virus That Infects 95% People

Scientists have developed new antibodies that could block Epstein-Barr virus (EBV), one of the world's most common viruses, according to Yahoo Finance.

HealthNews Info Wire2 min read
Scientists Develop Antibody for Virus That Infects 95% People

Scientists have developed new antibodies that could block Epstein-Barr virus (EBV), one of the world's most common viruses, according to Yahoo Finance.

Article outline

  1. What happened
  2. Why it matters
  3. The details
  4. The bottom line

Key points

  • Add ProPakistani to Preferred Sources and see more of our stories in Google Search and Top Stories.
  • Add as a preferredSource on Google Follow on Google News Join WhatsApp.
  • The research was published in Cell Reports Medicine.
  • The researchers applied specially bred mice capable of producing genetically human antibodies, potentially improving the chances that such antibodies could eventually be tested in residents.
  • The findings could be particularly significant for organ and bone marrow transplant patients.

EBV is estimated to infect regarding 95 percent of adults. It usually causes few or no symptoms, but the virus remains in the body for life and has been linked to a number of cancers, multiple sclerosis and other health difficulties. Health Authorities Intensify Measures as Chikungunya Outbreak Spreads.

Researchers from Fred Hutchinson Cancer Center and the University of Washington developed 10 new antibodies that target two proteins on the surface of EBV, known as gp350 and gp42. These proteins support the virus enter B cells. It are part of the immune system.

In experiments using mice with human-like immune systems, one of the antibodies provided solid protection against EBV infection.

For context, the researchers applied specially bred mice capable of producing genetically human antibodies, potentially improving the chances that such antibodies could eventually be tested in residents.

Meanwhile, the findings could be particularly significant for organ and bone marrow transplant patients. This person receive immune-suppressing medicines and face a higher risk of serious EBV-related complications.

Notably, the research was published in Cell Reports Medicine. More testing is needed before the antibodies can be evaluated as a treatment in humans. Stay Connected with ProPakistani. Obtain the latest news and stories wherever you prefer. Follow on Google Discover.

Taken together, the developments around scientists Develop Antibody for Virus That Infects 95% People point to a situation that is still moving, and the coming days should bring more clarity.

Leave a Reply

Your email address will not be published. Required fields are marked *